Kansas City, MO, United States of America

Gerold Mosher

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Azurity Pharmaceuticals Ireland Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerold Mosher. Retrieved from https://idiyas.com/inventor/gerold-mosher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerold Mosher: Innovator in Pharmaceutical Compositions

Introduction

Gerold Mosher is a notable inventor in the field of pharmaceuticals. He has contributed to the development of innovative compositions that enhance the efficacy of medications. His work primarily focuses on the combination of prasugrel and cyclodextrin derivatives.

Latest Patents

Although Gerold Mosher currently holds no patents, his significant invention is titled "Pharmaceutical Compositions Comprising Prasugrel And Cyclodextrin Derivatives And Methods Of Making And Using The Same." This invention is directed towards pharmaceutical compositions that incorporate prasugrel and a cyclodextrin derivative, along with methods for their production and application.

Career Highlights

Throughout his career, Gerold Mosher has demonstrated a commitment to advancing pharmaceutical science. His research has the potential to improve drug delivery systems and patient outcomes.

Collaborations

Gerold has worked alongside notable colleagues such as Stephen G Machatha and Daniel J Cushing. Their collaborative efforts have contributed to the development of innovative pharmaceutical solutions.

Conclusion

Gerold Mosher's contributions to pharmaceutical compositions highlight his role as an innovator in the field. His work continues to influence the development of effective medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…